A Clinical Trial of Convalescent Plasma Compared to Best Supportive Care for Treatment of Patients With Severe COVID-19
NCT04433910
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
106
Enrollment
OTHER
Sponsor class
Conditions
COVID-19
Interventions
DRUG:
Convalesscent Plasma
Sponsor
Deutsches Rotes Kreuz DRK-Blutspendedienst Baden-Wurttemberg-Hessen